Inclusion Criteria:~* The patient (or if applicable the legally acceptable representative (LAR) and if
different from the responsible caregiver) and the responsible caregiver are able to read and understand the
Informed Consent Form.~* The patient has a knowledgeable and reliable caregiver who will accompany the patient
to all clinic visits during the study.~* The patient (or if applicable the LAR and if different from the
responsible caregiver) and the responsible caregiver have signed the Informed Consent Form.~* The patient has
probable AD consistent with NINCDS-ADRDA criteria.~* The patient is a man or woman, aged at least 50 years.~*
The patient has been treated with donepezil on a stable dose for at least 3 months prior to screening.~
